165 related articles for article (PubMed ID: 7273265)
1. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
Workman P; Brown JM
Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
[TBL] [Abstract][Full Text] [Related]
2. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
Workman P; White RA
Biochem Pharmacol; 1982 Oct; 31(19):3041-6. PubMed ID: 6897355
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
Workman P
Cancer Chemother Pharmacol; 1980; 5(1):27-37. PubMed ID: 7460192
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
McManus ME; Monks A; Collins JM; White R; Strong JM
J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
White RA; Workman P
Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
8. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
Workman P; Twentyman PR
Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
[TBL] [Abstract][Full Text] [Related]
9. Studies on the O-demethylation of misonidazole by rat liver microsomes.
Shoemaker DD; McManus ME; Hoerauf R; Strong JM
Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
12. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
Workman P; Donaldson J; Smith NC
Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Chapman JD; Baer K; Lee J
Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
[TBL] [Abstract][Full Text] [Related]
14. Circadian changes in the elimination of misonidazole in mouse.
Labat C; Malmary MF; Casanovas AM; Patau JP; Oustrin J
Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):331-4. PubMed ID: 6658193
[TBL] [Abstract][Full Text] [Related]
15. Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitro.
Lee FY; Workman P; Cheeseman KH
Biochem Pharmacol; 1987 Apr; 36(8):1349-55. PubMed ID: 3593422
[TBL] [Abstract][Full Text] [Related]
16. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
Honess DJ; Workman P; Morgan JE; Bleehen NM
Br J Cancer; 1980 Apr; 41(4):529-40. PubMed ID: 7387851
[TBL] [Abstract][Full Text] [Related]
17. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
Workman P
Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
[TBL] [Abstract][Full Text] [Related]
18. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
[TBL] [Abstract][Full Text] [Related]
19. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
Born JL; Hadley WM
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
[TBL] [Abstract][Full Text] [Related]
20. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
Hirst DG; Hazlehurst JL; Brown JM
Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
